Viridian Therapeutics, Inc. (LON: 0K1R)
London
· Delayed Price · Currency is GBP · Price in USD 18.28
-0.62 (-3.28%)
Jan 22, 2025, 7:14 PM BST
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of 1.18 billion as of January 23, 2025. Its market cap has increased by 29.54% in one year.
Market Cap
1.18B
Enterprise Value
740.88M
Revenue
225.32K
Ranking
n/a
PE Ratio
n/a
Stock Price
18.28
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 138.06M to 1.18B, an increase of 754.84%. That is a compound annual growth rate of 31.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.60B |
| GSK plc | 55.45B |
| Haleon | 33.80B |
| Smith & Nephew | 8.94B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 4.63B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |